Pneumonia News and Research

RSS
Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.
Specific bacterial toxins reduce number of cells suppressing immune response

Specific bacterial toxins reduce number of cells suppressing immune response

Antibiotic resistance data from across the globe released

Antibiotic resistance data from across the globe released

Gladstone scientists gain new insights into the aging brain

Gladstone scientists gain new insights into the aging brain

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Study shows how pneumococci challenge the immune system

Study shows how pneumococci challenge the immune system

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

AI in medical space must be carefully tested for performance across wide range of populations

AI in medical space must be carefully tested for performance across wide range of populations

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Measles can be deadly for people with weakened immune systems

Measles can be deadly for people with weakened immune systems

Getting right level of leptin may help protect cardiovascular health

Getting right level of leptin may help protect cardiovascular health

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Who knew? Life begins (again) at 65

Who knew? Life begins (again) at 65

Synspira’s abstracts accepted for presentation at the 32nd Annual NACFC

Synspira’s abstracts accepted for presentation at the 32nd Annual NACFC

Researchers identify molecule that plays key role in bacterial communication, infection

Researchers identify molecule that plays key role in bacterial communication, infection

Will Maine voters decide to make aging in place affordable?

Will Maine voters decide to make aging in place affordable?